Sonia Toussaint-Caire

Dr. Sonia Toussaint-Caire

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2018 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
STSonia Toussaint-Caire
Sonia Toussaint-Caire
AWAlejandro Woroszylski-Yoselevitz
Alejandro Woroszylski-Yoselevitz
MMMa Elisa Veja Memiije
Ma Elisa Veja Memiije
GVGuiehdani Villalobos
Guiehdani Villalobos
NRNancy Rivas
Nancy Rivas
FMFernando Martínez-Hernández
Fernando Martínez-Hernández
Dermatobia hominis is a fly endemic to and widely distributed throughout the Americas; it is found from the southern regions of Mexico to Argentina. However, because of widespread travel, myiasis has become common in countries where neither the disease nor the species that cause this infection are endemic. Central Mexico, for instance, is not a region where myiasis is endemic. We, thus, describe three cases of D. hominis myiasis: two autochthonous cases from the southern part of Mexico and one imported from Costa Rica. In addition, morphological and genetic identification was performed on the maggots extracted from the patients.

23 November 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
Carmen Rodriguez-CerdeiraCarmen Rodriguez-Cerdeira
Carmen Rodriguez-Cerdeira
RHRigoberto Hernandez-Castro
Rigoberto Hernandez-Castro
CSCarlos Sánchez
Carlos Sánchez
RARoberto Arenas
Roberto Arenas
AMAlejandro Meza-Robles
Alejandro Meza-Robles
Erick Martínez HerreraErick Martínez Herrera
Erick Martínez Herrera
Background: Members of Micobacterium. abscessus complex comprises three subspecies (M. abscessus subsp. Abscessus, M. abscessus subsp. Bolletii, and M. abscessus subsp. Massiliense) and are a rapid-growing nontuberculous mycobacteria present in different aquatic habitats and soil. It often causes a wide spectrum of infections involving pulmonary infections, surgical wound infections, and infections related to mesotherapy, catheters, hemodialysis devices, endocarditis, and disseminated infections in immunocompromised individuals. Methods: In this article we comment on the most relevant aspects of nine patients with skin lesions caused by M. abscessus subsp. massiliense infection. Clinical characteristics, histopathology, and molecular identification were performed. Results: The patients in the clinical cases presented a history of trauma, tattoos, and physical therapy techniques. The most common treatments were minocycline and clindamycin, doxycycline, ceftriaxone, cephalexin, moxifloxacin, rifampicin, and trimethoprim-sulfamethoxazole. The evolution of the treated patients was acceptable, except for one patient, who showed a partial improvement. M. massiliense were identified in all clinical cases using a species-specific PCR. Conclusion: Our series consisted of nine cases of skin biopsies recorded in different years; for this reason, we do not have all the data necessary for a complete description, in particular in four cases, causing limitations in the manuscript, especially in the therapy used and the evolution of patients due to lack of follow-up.

13 August 2016 in Skin Appendage Disorders
Verified
Journal Article
Open access
PDF file
APAdriana Peña-Romero
Adriana Peña-Romero
STSonia Toussaint-Caire
Sonia Toussaint-Caire
JDJudith Domínguez-Cherit
Judith Domínguez-Cherit
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

21 October 2020 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
APAdriana Guadalupe Peña‐Romero
Adriana Guadalupe Peña‐Romero
MOMarimar M. Saez De Ocariz-Gutierrez
Marimar M. Saez De Ocariz-Gutierrez
STSonia Toussaint-Caire
Sonia Toussaint-Caire
EMEdna Morán‐Villaseñor
Edna Morán‐Villaseñor
LOLuz Orozco‐Covarrubias
Luz Orozco‐Covarrubias
CDCarola Duran-McKinster
Carola Duran-McKinster

21 November 2018 in Skin Appendage Disorders
Verified
Journal Article
Closed access
PDF file
CCClaudia Contreras-Rivera
Claudia Contreras-Rivera
STSonia Toussaint-Caire
Sonia Toussaint-Caire
RFRamón Fernández-Martínez
Ramón Fernández-Martínez
GMGabriela Moreno-Coutiño
Gabriela Moreno-Coutiño
Background: Onychomycosis is one of the most common nail diseases and constitutes up to 50% of all nail conditions. It is a chronic fungal nail infection common in the HIV-infected population. Few studies have found fungal organisms in the nail without clinical evidence, and thus, termed subclinical onychomycosis. Objectives: We analyzed the nails of the HIV population in our hospital, searching for subclinical onychomycosis. Method: A distal nail clipping was stained with PAS and observed by a trained dermatopathologist. Results: All of our samples (n = 48) turned out to be negative for fungal structures. Conclusions: The epidemiology of onychomycosis is changing, treatment options are much better now, and diagnosis and infection detection are being done earlier. Therefore, we will continue to further study this disease in other patient populations so that we can compare our results and see whether the incidence of onychomycosis in the HIV population is now similar to that in those without HIV infection of the same age.

1 January 2021 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
MRMarian Kristalia Rivas‐Calderón
Marian Kristalia Rivas‐Calderón
OCOrly Cheirif‐Wolosky
Orly Cheirif‐Wolosky
MRMaria Eugenia Rosas‐Romero
Maria Eugenia Rosas‐Romero
STSonia Toussaint-Caire
Sonia Toussaint-Caire
CDCarola Duran-McKinster
Carola Duran-McKinster
MGMaria Teresa García-Romero
Maria Teresa García-Romero